✦ LIBER ✦

Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients

✍ Scribed by Bain, Vincent G.; Kaita, Kelly D.; Marotta, Paul; Yoshida, Eric M.; Swain, Mark G.; Bailey, Robert J.; Patel, Keyur; Cronin, Patrick W.; Pulkstenis, Erik; McHutchison, John G.

Book ID: 123027622
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 300 KB
Volume: 6
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2008.02.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Albinterferon alfa-2b dosed every two or

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

✍ Stefan Zeuzem; Eric M. Yoshida; Yves Benhamou; Stephen Pianko; Vincent G. Bain; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The efficacy and safety of albinterferon alfa-2b (alb-IFN), a novel recombinant protein consisting of interferon alfa-2b genetically fused to human albumin, was evaluated in a phase 2b, open-label study of patients with genotype 1, chronic hepatitis C. In all, 458 IFN-alfa treatment-naı ¨ve patients

Randomized trial of albinterferon alfa-2

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

✍ S. Pianko; S. Zeuzem; W.-L. Chuang; G. R. Foster; S. K. Sarin; R. Flisiak; C.-M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Safety and Antiviral Activity of Albinte

Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C

✍ Nelson, David R.; Rustgi, Vinod; Balan, Vijayan; Sulkowski, Mark S.; Davis, Gary 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 810 KB

1042 EFFICACY AND SAFETY RESULTS OF ALBI

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

817 POSITIVE PREDICTIVE VALUE OF EARLY A

817 POSITIVE PREDICTIVE VALUE OF EARLY ANTIVIRAL RESPONSE PROFILE WITH ALBINTERFERON ALFA-2B IN IFN-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ A.U. Neumann; S. Zeuzem; E. Yoshida; Y. Benhamou; S. Pianko; J.G. McHutchison; E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

269 DYNAMICS OF APOPTOTIC ACTIVITY IN PA

269 DYNAMICS OF APOPTOTIC ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH ALBINTERFERON ALFA-2B OR PEGINTERFERON ALFA-2A

✍ B. Kronenberger; E. Herrmann; C. Chen; M. Fiscella; G. Subramanian; J. McHutchis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB